New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit…
Year: 2025
Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today – Quartz
Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today Quartz
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani…
Eating in This Order Could Have Similar Benefits to Ozempic – Parade Magazine
Eating in This Order Could Have Similar Benefits to Ozempic Parade Magazine
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults – BioSpace
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant…
Could popular weight-loss drugs help treat addiction and dementia? – AAMC
Could popular weight-loss drugs help treat addiction and dementia? AAMC
Could popular weight-loss drugs help treat addiction and dementia? – AAMC
Could popular weight-loss drugs help treat addiction and dementia? AAMC
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial – Pharmacy Times
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial Pharmacy Times
Emergent signs financial investment agreement with Swiss Rockets
Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech…
China’s weight-loss drive: What it means for brands – Jing Daily
China’s weight-loss drive: What it means for brands Jing Daily